Back

The Morbidity Costs of Air Pollution through the Lens of Health Spending in China

Zhang, X.; Zhang, X.; Chen, X.; Liu, Y.; Zhao, X.

2021-09-15 health policy
10.1101/2021.09.11.21256274 medRxiv
Show abstract

This study offers one of the first causal evidence on the morbidity costs of fine particulates (PM2.5) for all age cohorts in a developing country, using individual-level healthcare spending data from the basic medical insurance program in Wuhan, China. Our instrumental variable (IV) approach uses thermal inversion to address potential endogeneity in PM2.5 concentrations and shows that PM2.5 imposes a significant impact on medical expenditures. The IV estimate suggests that a 10 g/m3 reduction in monthly average PM2.5 leads to a 2.79% decrease in the value of health spending and a 0.70% decline in the number of transactions in pharmacies and health facilities. The effect is more salient for males, children, and older adults. Moreover, our estimates provide a lower bound of peoples willingness-to-pay, which amounts to CNY 51.85 (or USD 8.38) per capita per year for a 10 g/m3 reduction in PM2.5. JEL CodesQ51, Q53, I11, I31 Conflict of interestThe authors declare that they have no conflict of interest.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.